GlassScriptPhysician profile
Mark P Figgie
NPI 1912550450
$897.32
in general payments reported to CMS, 2019-2025
9 companies · $428 in 2025
The $428 reported for 2025 was less than what a typical Neuromuscular Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $530).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $71.56 · 2022: $120 · 2023: $165 · 2024: $112 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $706.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $705.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Highridge Medical LLC | $216.26 | 2025 | Vital Deformity, Degen, Hooks (S114), Vital |
| Think Surgical, INC. | $185.09 | 2025 | |
| Genzyme Corporation | $172.79 | 2021-2023 | |
| Ucb, INC. | $112.19 | 2024 | |
| Emd Serono, INC. | $90.46 | 2022-2023 | Mavenclad |
| Alexion Pharmaceuticals, INC. | $55.34 | 2022-2023 | Ultomiris |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.65 | 2025 | Jardiance |
| Averitas Pharma INC. | $24.08 | 2023 | Qutenza |
| Lilly USA, LLC | $14.46 | 2023 | Amyvid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Figgie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.